Literature DB >> 21056516

Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections.

Odile Wauters1, Eglantine Lebas, Arjen F Nikkels.   

Abstract

Chronic herpes simplex virus (CHSV) and chronic varicella zoster virus (CVZV) are defined as atypical mucocutaneous wart-like and/or ulcerative HSV or VZV infections, persisting for at least 1 month. Both are commonly associated with HIV infection and may occasionally present with other types of immunosuppression. CHSV and CVZV occur despite the immune restoration effect of highly active antiretroviral therapy for HIV. The clinical polymorphism of CHSV and CVZV makes recognition difficult. Histology, immunohistology, PCR and viral culture all help to confirm the diagnosis. Treatment is frequently complicated by resistance to thymidine kinase (TK)-dependent antivirals, including acyclovir, valacyclovir and famciclovir. Viral culture remains an essential tool for antiviral drug susceptibility testing. Therapeutic alternatives include non-TK-dependent antivirals, such as foscarnet or cidofovir, which directly target viral DNA polymerase. With few exceptions, CHSV and CVZV infections do not constitute significant risk factors for disseminated cutaneous or systemic infection. This review compares the similarities of and differences between CHSV and CVZV infections.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056516     DOI: 10.1016/j.jaad.2010.07.011

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 2.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

Review 3.  The alpha-herpesviridae in dermatology : Herpes simplex virus types I and II.

Authors:  L El Hayderi; A Rübben; A F Nikkels
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

Review 4.  [The alpha-herpesviridae in dermatology : Herpes simplex virus types I and II. German version].

Authors:  L El Hayderi; A Rübben; A F Nikkels
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

Review 5.  The alpha-herpesviridae in dermatology : Varicella zoster virus.

Authors:  L El Hayderi; A Rübben; A F Nikkels
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

Review 6.  [The alpha-herpesviridae in dermatology : Varicella zoster virus. German version].

Authors:  L El Hayderi; A Rübben; A F Nikkels
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

7.  Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Jessica Leung; Subhadra Siegel; James F Jones; Cynthia Schulte; Debra Blog; D Scott Schmid; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

8.  Prevention of infection caused by immunosuppressive drugs in gastroenterology.

Authors:  Katarzyna Orlicka; Eleanor Barnes; Emma L Culver
Journal:  Ther Adv Chronic Dis       Date:  2013-07       Impact factor: 5.091

9.  Chronic ulcerative herpes simplex virus infection of the vulva.

Authors:  Kelly Griffith-Bauer; Mary O'Hearn; Benjamin D Ehst
Journal:  Case Rep Dermatol       Date:  2012-09-12

Review 10.  Chronic mucocutaneous anogenital herpes: series of ten cases and literature review.

Authors:  Karina Baruel de Camargo Votto Calbucci; John Verrinder Veasey
Journal:  An Bras Dermatol       Date:  2022-03-16       Impact factor: 2.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.